ACI Group: Building impact across Bangladesh's economy
When Advanced Chemical Industries (ACI) began its journey as the successor to ICI Bangladesh more than three decades ago, it was primarily known for chemicals and pharmaceuticals. Today, its footprint extends far beyond its origins, reaching farms, hospitals, supermarkets, households and industrial supply chains across the country.
That breadth of operations is reflected in the BRAC Bank Impact Awards 2026, where ACI Group ranked 19th overall with an average score of 7.40, placing it among Bangladesh's most impactful organisations.
ACI's transformation mirrors the changing needs of Bangladesh's economy. Rather than relying on a single business line, the group has expanded into healthcare, consumer brands, agribusiness, motors and retail, creating a diversified business model that touches multiple sectors critical to economic development. According to the company's latest annual report, the group now operates through 17 subsidiaries and several joint ventures and associate companies. It also employs more than 13,500 people nationwide and contributed Tk22.7 billion to the national exchequer through taxes, duties and VAT during FY2024-25.
Its influence is particularly visible in agriculture, where ACI has built one of Bangladesh's largest integrated agribusiness platforms. The company supplies crop protection products, seeds, fertilisers, animal health products and farm machinery, serving farmers across the country. Through ACI Motors, it has also expanded access to mechanised farming equipment, reflecting the growing demand for higher agricultural productivity as labour shortages reshape rural Bangladesh.
The group's retail business has become another defining pillar. Operated through Shwapno, ACI runs Bangladesh's largest supermarket network, with more than 680 outlets nationwide according to the company. Beyond organised retail, the chain has invested in modern sourcing systems, food safety standards and direct procurement from farmers, helping connect agricultural producers with urban consumers through formal supply chains.
Healthcare remains another core business. ACI Pharmaceuticals continues to be one of the country's established pharmaceutical manufacturers, while the broader healthcare division supplies medicines, medical devices and consumer healthcare products. Together with its consumer brands portfolio, the company's businesses have become familiar names in many Bangladeshi households.
Financially, the past year has illustrated both the opportunities and challenges facing diversified conglomerates. ACI's consolidated revenue reached Tk13,790 crore in FY2024-25, up nearly 11% from the previous year. Although higher borrowing costs continued to weigh on profitability, the company narrowed its consolidated losses through stronger revenue growth and improved cost management. More recent financial disclosures also show the company returning to profit during the first half of FY2025-26, supported by growth across several business segments.
The group's continued expansion suggests it is still looking beyond its traditional businesses. Earlier this year, ACI announced plans to establish subsidiaries focused on semiconductor and property businesses, signalling an intention to diversify further as Bangladesh's economy becomes increasingly technology-driven.
Ranking among the country's most impactful organisations reflects more than commercial performance alone. ACI's businesses operate across sectors that directly influence food security, healthcare access, consumer markets and agricultural productivity—areas that affect millions of Bangladeshis every day.
As Bangladesh moves toward a more diversified and industrialised economy, companies with broad-based operations are likely to play an increasingly important role. ACI's journey from a chemical manufacturer to one of the country's largest conglomerates illustrates how corporate growth can become intertwined with national development, even as the company continues to navigate rising financing costs and an increasingly competitive business environment.
